Crispr Therapeutics shares owned by Buckland Partners Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Buckland Partners Management
from 13F filings
Historical chart of Buckland Partners Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Buckland Partners Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Buckland Partners Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $218k | 4.0k | 54.54 |
More positions owned by Buckland Partners Management
View all positions for Buckland Partners Management